XenoPort, Inc. (NASDAQ:XNPT)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs.

Recs

2
Player Avatar PapiShasho (< 20) Submitted: 2/19/2010 1:30:30 PM : Outperform Start Price: $7.32 XNPT Score: -38.34

oversold

Featured Broker Partners


Advertisement